Whoever said uncertainty is the only certainty there is must have been speaking of 2017. The Trump Administration coupled with a Republican majority in control of both chambers of the new 115th Congress has left the future of the Patient Protection and Affordable Care Act (ACA) (P.L. 111-148) enormously uncertain. What’s at risk?
- Expanded access to health insurance through private health insurance, employer-provided health plans, and Medicaid.
- Premium support to individuals to health pay for insurance.
- Financial incentives to insurance companies and states to expand health insurance.
- Broader coverage of basic preventive health services.
- Various taxes and fees enacted to health pay for expanded coverage.
- The unforeseen impact on the FDA’s regulation of drugs, food, cosmetics, and medical devices.
This White Paper compares Trump’s campaign promises related to health care with the actions taken thus far by the executive branch and Congress. At the time this White Paper was drafted, there were close to 100 bills introduced before the 115th Congress that would affect the health care industry, from repealing and replacing the ACA to negotiating Medicare prescription drug prices, and many others impacting the ACA, Medicare, and Medicaid. The President has signed two Executive Orders (EOs) directly affecting the industry. The first, signed just hours after Trump took the oath of office, sets the course for repeal of the ACA. The second, signed on January 30, 2017 will have a wide-reaching effect on all government agencies. Trump’s nominees for HHS Secretary (Rep. Tom Price, M.D. (R- Ga)), CMS Administrator (Seema Verma), and to fill the Supreme Court vacancy (Judge Neil Gorsuch) are proving contentious. But no real movement has been made to repeal the ACA, despite health care being labeled Trump’s top priority, and Congress has certainly not offered any one viable replacement plan.
This White Paper will specifically discuss the varying options for dismantling the ACA and what that would mean for specific programs offered under the ACA, as well as what the Trump presidency and new Congress may mean for other areas of health care and life sciences.
Then join our experts as they review these events and their ongoing impact well into 2017. Webinar Replay for the March 8, 2017, webinar.
Attorneys: (Kellogg, Huber, Hansen, Todd, Evans & Figel, PLLC). Colin Roskey (Alston & Bird, LLP). Gerald "Jud" E. DeLoss (Greensfelder, Hemker & Gale, P.C.). Susan A. Benz (Barclay Damon LLP).
Companies: Health Care Compliance Association
MainStory: WhitePapers NewsFeed AccessNews AgencyNews CostSharingNews EmployerMandateNews EnrollmentNews EssentialBenefitNews FederalFMAPNews FoodNews FraudNews GeneralNews HealthInsuranceExchangeNews IndividualMandateNews InsurerNews MedicaidNews MedicaidExpansionNews MedicalDeviceNews MedicalDeviceTaxNews MedicarePartANews MedicarePartBNews MedicarePartCNews MedicarePartDNews PremiumTaxNews TrumpAdministrationNews
Interested in submitting an article?
Submit your information to us today!Learn More